Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 4
2006 3
2007 3
2008 2
2009 4
2010 9
2011 8
2012 9
2013 7
2014 9
2015 17
2016 25
2017 19
2018 24
2019 32
2020 51
2021 66
2022 53
2023 45
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

353 results

Results by year

Filters applied: . Clear all
Page 1
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D; EXPLORER-HCM study investigators. Olivotto I, et al. Among authors: wojakowski w. Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29. Lancet. 2020. PMID: 32871100 Clinical Trial.
Polypill Strategy in Secondary Cardiovascular Prevention.
Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, Sanchez PL, Marin Ortuño F, Vazquez Rodriguez JM, Domingo-Fernández A, Lozano I, Roncaglioni MC, Baviera M, Foresta A, Ojeda-Fernandez L, Colivicchi F, Di Fusco SA, Doehner W, Meyer A, Schiele F, Ecarnot F, Linhart A, Lubanda JC, Barczi G, Merkely B, Ponikowski P, Kasprzak M, Fernandez Alvira JM, Andres V, Bueno H, Collier T, Van de Werf F, Perel P, Rodriguez-Manero M, Alonso Garcia A, Proietti M, Schoos MM, Simon T, Fernandez Ferro J, Lopez N, Beghi E, Bejot Y, Vivas D, Cordero A, Ibañez B, Fuster V; SECURE Investigators. Castellano JM, et al. N Engl J Med. 2022 Sep 15;387(11):967-977. doi: 10.1056/NEJMoa2208275. Epub 2022 Aug 26. N Engl J Med. 2022. PMID: 36018037 Clinical Trial.
Drug-Eluting Stents: Technical and Clinical Progress.
Koźlik M, Harpula J, Chuchra PJ, Nowak M, Wojakowski W, Gąsior P. Koźlik M, et al. Among authors: wojakowski w. Biomimetics (Basel). 2023 Feb 9;8(1):72. doi: 10.3390/biomimetics8010072. Biomimetics (Basel). 2023. PMID: 36810403 Free PMC article. Review.
Myocardial infarction in the shadow of COVID-19.
Wańha W, Wybraniec M, Kapłon-Cieślicka A, Kupczyńska K, Dobrowolski P, Michalski B, Darocha S, Domienik-Karłowicz J, D'Ascenzo F, Kaźmierski M, Januszek R, Bartuś S, Witkowski A, Dudek D, Wojakowski W, Jaguszewski MJ. Wańha W, et al. Among authors: wojakowski w. Cardiol J. 2020;27(5):478-480. doi: 10.5603/CJ.2020.0152. Cardiol J. 2020. PMID: 33165896 Free PMC article. No abstract available.
Incretin drugs as modulators of atherosclerosis.
Gallego-Colon E, Wojakowski W, Francuz T. Gallego-Colon E, et al. Among authors: wojakowski w. Atherosclerosis. 2018 Nov;278:29-38. doi: 10.1016/j.atherosclerosis.2018.09.011. Epub 2018 Sep 14. Atherosclerosis. 2018. PMID: 30248550 Review.
Nanotechnology and stem cells in vascular biology.
Jadczyk T, Caluori G, Wojakowski W, Starek Z. Jadczyk T, et al. Among authors: wojakowski w. Vasc Biol. 2019 Sep 24;1(1):H103-H109. doi: 10.1530/VB-19-0021. eCollection 2019. Vasc Biol. 2019. PMID: 32923961 Free PMC article. Review.
The Year in Cardiology 2018: Valvular Heart Disease.
Wojakowski W, Baumgartner H. Wojakowski W, et al. Eur Heart J. 2019 Feb 1;40(5):414-421. doi: 10.1093/eurheartj/ehy893. Eur Heart J. 2019. PMID: 30602001 Review. No abstract available.
Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
Windecker S, Latib A, Kedhi E, Kirtane AJ, Kandzari DE, Mehran R, Price MJ, Abizaid A, Simon DI, Worthley SG, Zaman A, Hudec M, Poliacikova P, Abdul Ghapar AKB, Selvaraj K, Petrov I, Mylotte D, Pinar E, Moreno R, Fabbiocchi F, Pasupati S, Kim HS, Aminian A, Tie C, Wlodarczak A, Hur SH, Marx SO, Jankovic I, Brar S, Bousquette L, Liu M, Stone GW; ONYX ONE Investigators. Windecker S, et al. N Engl J Med. 2020 Mar 26;382(13):1208-1218. doi: 10.1056/NEJMoa1910021. Epub 2020 Feb 12. N Engl J Med. 2020. PMID: 32050061 Free article. Clinical Trial.
353 results